A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Vodolazkaia, Alexandra ^a,c   Bossuyt, Xavier ^c   Fassbender, Amelie ^a,c   Kyama, Cleophas M ^a,b,c   Meuleman, Christel ^a   Peeraer, Karen ^a   Tomassetti, Carla ^a   D'Hooghe, Thomas M ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b INSTITUTE OF PRIMATE RESEARCH   (Kenya)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ARTICLE; BIOASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; FOLLICULAR PHASE; HUMAN; INTERMETHOD COMPARISON; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; COMPARATIVE STUDY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENDOMETRIOSIS; FEMALE; HUMANS; LUTEAL PHASE; SENSITIVITY AND SPECIFICITY;

EID: 79961131359     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-113     Document Type: Article

References (36)

1. Mihalyi A, Kyama CM, Simsa P, Debrock S, Mwenda JM, D'Hooghe TM. Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies. Therapy 2005, 2:623-639.
2. D'Hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and subfertility: Is the relationship resolved?. Semin Reprod Med 2003, 21:243-254.
3. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003, 123:1-9.
4. Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I, Vassiliadis S. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 2003, 3:81-89. 10.1016/S1567-5769(02)00216-3, 12538037.
5. Vigano P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clinical Obstet Gynaecl 2004, 18:177-200.
6. Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: Promises and pitfalls. Clin Chem Lab Med 2001, 39:1171-1176. 10.1515/CCLM.2001.185, 11831635.
7. Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with Systemic Subclinical Inflammation?. Gynecol Obstet Invest 2006, 62:139-147. 10.1159/000093121, 16679772.
8. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999, 45:2136-2141.
9. Verma S, Yeh ET. C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol 2003, 285:R1250-1252.
10. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004, 279:48487-48490. 10.1074/jbc.R400025200, 15337754.
11. Abrao MS, Podgaec S, Filho BM, Ramos LO, Pinotti JA, de Oliveira RM. The use of biochemical markers in the diagnosis of pelvic endometriosis. Hum Reprod 1997, 12:2523-2527. 10.1093/humrep/12.11.2523, 9436699.
12. Xavier P, Belo L, Beires J, Rebelo I, Lunet N, Barros H. Serum levels of VEGF and TNF-a And their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 2006, 273:227-231. 10.1007/s00404-005-0080-4, 16208475.
13. Lermann J, Mueller A, Korber F, Oppelt P, Beckmann R, Dittrich R, Renner SP. Evaluation of high-sensitivity reactive protein in comparison with C-reactive protein as biochemical serum marker in women with endometriosis. Fertil Steril 2010, 93:2125-2129. 10.1016/j.fertnstert.2009.01.072, 19232412.
14. Mihalyi A, Gevaert O, Kyama CM, Simsa P, Pochet N, De Smet F, De Moor B, Meuleman C, Billen J, Blanckaert N, et al. Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod 2010, 25:654-664. 10.1093/humrep/dep425, 20007161.
15. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010, (16):651-674.
16. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25. 10.1186/1471-2288-3-25, 305345, 14606960.
17. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2 Clin Chem 2001, 47:418-425.
18. D'Hooghe TM, Mihalyi AM, Simsa P, Kyama CK, Peeraer K, De Loecker P, Meeuwis L, Segal L, Meuleman C. Why we need a non-invasive diagnostic test for minimal to mild endometriosis with a high sensitivity. Editorial and Opinion Paper Gynecol Obstet Invest 2006, 62:136-138.
19. Hawass NED. Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients. Br J Radiol 1997, 70:360-366.
20. Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmunity Reviews 2009, 8:543-548. 10.1016/j.autrev.2009.01.013, 19200856.
21. Akobeng A. Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 2007, 96:644-647. 10.1111/j.1651-2227.2006.00178.x, 17376185.
22. Waaseth M, Bakken K, Dumeaux V, Olsen K, Rylander C, Figenschau Y, Lund E. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort -a cross-sectional analysis. BMC Womens Health 2008, 8:1-11. 10.1186/1472-6874-8-1, 2254595, 18194511.
23. De Long ER, De Long DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
24. Royal HD, McNeil BJ. Quantitative analysis in clinical nuclear medicine. Clinical Nuclear Medicine 1983, 473-479. London: Chapman & Hall Ltd, 1.
25. Glantz AS. Primer of Bio-statistics 1992, 32-33. New York: Mc Graw Hill, Inc, 3.
26. Gewurz H. Biology of C-reactive protein and the acute phase response. Hosp Pract 1982, 17:67-71.
27. Singer JM, Plotz CM, Bader E, Elster SK. The latex-fixation test. III. Agglutination test for C-reactive protein and comparison with the capillary precipitin method. Am J Clin Pathol 1957, 28:611-617.
28. Patel P, Mendall M, Carrington DJ, Strachan D, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, et al. Association of Helicobacter pylori and Chlamidia pheumoniae infection with coronary heart disease and cardiovascular risk factor. Br Med J 1995, 311:711-714.
29. Poddubnyy DA, Rudwaleit M, Listing J, Braun J, Sieper J. Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Annals of the Rheumatic Diseases 2010, 69:1338-1341. 10.1136/ard.2009.120139, 20498207.
30. Malek A, Bersinger NA, Di Santo S, Mueller MD, Sager R, Schneider H, Ghezzi F, Karousou E, Passi A, De Luca G, Raio L. C-Reactive Protein Production in Term Human Placental Tissue. Placenta 2006, 27:619-625. 10.1016/j.placenta.2005.05.009, 16026834.
31. Kalsch AI, Csernok E, Munch D, Birck R, Yard BA, Gross W, Kalsch T, Schmitt WH. Use of Highly Sensitive C-Reactive Protein for Followup of Wegener's Granulomatosis. Journal of Rheumatology 2010, 37:2319-2325. 10.3899/jrheum.100302, 20716656.
32. Ridker PM. High-sensitivity C-reactive protein - Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001, 103:1813-1818.
33. Pretta S, Remorgida V, Abbamonte LH, Anserini P, Ragni N, Del Sette M, Gandolfo C, Ferrero S. Atherosclerosis in women with endometriosis. Eur J Obstet Gynecol Reprod Biol 2007, 132:226-231. 10.1016/j.ejogrb.2006.04.015, 16682112.
34. Angstwurm M, Gartner R, Ziegler-Heitbrock H. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 1997, 9:370-374. 10.1006/cyto.1996.0178, 9195137.
35. Jilma B, Dirnberger E, Löscher I, Rumplmayr A, Hildebrandt J, Eichler H, Stylianos K, Wagner O. Menstrual cycle-associated changes in blood levels of interleukin-6, α1 acid glycoprotein, and C-reactive protein. Journal of Laboratory and Clinical Medicine 1997, 130:69-75. 10.1016/S0022-2143(97)90060-3, 9242368.
36. Matarese G, Alviggi C, Sanna V, Howard JK, Lord GM, Carravetta C, Fontana S, Lechler RI, Bloom SR, De Placido G. Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab 2000, 85:2483-2487. 10.1210/jc.85.7.2483, 10902797.